Connect with us

BIOTECH

InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) Updates Pain Program

Published

on

InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) reported additional pre-clinical data in the advancement of INM-405 for the cure of pain. In recent pre-clinical assessment, the company employed numerous methods to substantiate the effects of individual, non-THC cannabinoids, and a matrix of cannabinoid combinations, offered to cure peripheral pain.

These methods include in vivo animal models of pain to estimate the pain tolerance; in vivo behavioral trials to verify the CNS related side effects; and in vivo electrophysiology recordings to know the blockage of pain signal spread in the peripheral nerve fibres.

The highlights

Results from the recent data indicate that peripheral application of specific cannabinoid compounds, in combination or alone, is effective in the cure of craniofacial muscle pain disorders, with no CNS side effects noted, and may be a more desirable plan as compared to systemic pain-relief administration.

Previously, InMed announced the expression of both CB2 and CB1 receptors in trigeminal ganglion neurons stimulating the masseter muscle, offering indication that these receptors can be marks for craniofacial muscle pain. CB2 and CB1 receptors are main targets in the body for cannabinoid medications.

There is a requirement to find options to treat severe and chronic pain that have limited side effects and are non-addictive. InMed continues to work upon the potential of non-THC Hemps to treat pain utilizing a topical formulation. The company’s proof of concept trial data published in the European Journal of Pain this July, showcased the topical use of THC to successfully cure peripheral pain.

Recently, the company submitted a provisional patent application in the U.S. for INM-405 and other innovative compositions as Hemp-based topical therapies for the cure of pain, which is a vital step in safeguarding InMed’s commercial and intellectual property. The base of this patent is the unreported results, mentioned above, on non-THC Hemps and their ability to regulate pain. The patent mentions a range of Hemps, alone or in combination, smeared topically to treat several types of pain – nerve, arthritis-induced joint pain, muscle, etc.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized1 day ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health2 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business2 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business2 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business2 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP2 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP2 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP2 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

INDUSTRIAL HEMP2 weeks ago

Kush Bottles Inc (OTCMKTS:KSHB)’ Q1 Results For Fiscal Year 2018 Released

Leading supplier and service provider to the cannabis sector, Kush Bottles Inc (OTCMKTS:KSHB), has released financial results for 2018’s first...

INDUSTRIAL HEMP2 weeks ago

Wanderport Corp. (OTCMKTS:WDRP) Will Accept The Use Of Bitcoin In Its E-Commerce Store

Wanderport Corp. (OTCMKTS:WDRP) has made good its promise of allowing full access to the Company’s full suite of products. The...

Advertisement
Advertisement